Which has better valuation and earnings, DCGO or LFMD?

LifeMD has lower revenue, but higher earnings than DocGo. LifeMD is trading at a lower price-to-earnings ratio than DocGo, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio DocGo $322.20M 0.12 -$182.40M -$1.96 N/A LifeMD $194.05M 0.77 $14.35M -$0.05 N/A

Is DCGO or LFMD more profitable?

LifeMD has a net margin of 0.10% compared to DocGo's net margin of -65.29%. DocGo's return on equity of -40.42% beat LifeMD's return on equity. Company Net Margins Return on Equity Return on Assets DocGo -65.29% -40.42% -24.81% LifeMD 0.10% -168.23% -31.27%

Do analysts prefer DCGO or JYNT?

DocGo presently has a consensus target price of $2.38, suggesting a potential upside of 489.77%. Given DocGo's stronger consensus rating and higher probable upside, equities analysts clearly believe DocGo is more favorable than Joint. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score DocGo 1 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.33 Joint 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has preferable earnings and valuation, DCGO or JYNT?

Joint has lower revenue, but higher earnings than DocGo. DocGo is trading at a lower price-to-earnings ratio than Joint, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio DocGo $322.20M 0.12 -$182.40M -$1.96 N/A Joint $54.90M 2.14 $2.91M $0.27 30.81

Is DCGO or JYNT more profitable?

Joint has a net margin of 6.49% compared to DocGo's net margin of -65.29%. Joint's return on equity of 12.02% beat DocGo's return on equity. Company Net Margins Return on Equity Return on Assets DocGo -65.29% -40.42% -24.81% Joint 6.49% 12.02% 3.47%

Does the media prefer DCGO or JYNT?

In the previous week, Joint had 1 more articles in the media than DocGo. MarketBeat recorded 2 mentions for Joint and 1 mentions for DocGo. Joint's average media sentiment score of 0.34 beat DocGo's score of 0.00 indicating that Joint is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DocGo 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Joint 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Is DCGO or ACH more profitable?

Accendra Health has a net margin of -11.41% compared to DocGo's net margin of -65.29%. Accendra Health's return on equity of -4.02% beat DocGo's return on equity. Company Net Margins Return on Equity Return on Assets DocGo -65.29% -40.42% -24.81% Accendra Health -11.41% -4.02% 0.70%

Does the media prefer DCGO or ACH?

In the previous week, DocGo and DocGo both had 1 articles in the media. Accendra Health's average media sentiment score of 1.70 beat DocGo's score of 0.00 indicating that Accendra Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DocGo 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Accendra Health 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Which has stronger earnings & valuation, PIII or DCGO?

P3 Health Partners has higher revenue and earnings than DocGo. P3 Health Partners is trading at a lower price-to-earnings ratio than DocGo, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio P3 Health Partners $1.46B 0.05 -$147.95M -$33.00 N/A DocGo $322.20M 0.12 -$182.40M -$1.96 N/A

Is PIII or DCGO more profitable?

P3 Health Partners has a net margin of -6.55% compared to DocGo's net margin of -65.29%. P3 Health Partners' return on equity of 0.00% beat DocGo's return on equity. Company Net Margins Return on Equity Return on Assets P3 Health Partners -6.55% N/A -16.40% DocGo -65.29% -40.42% -24.81%

Does the media favor PIII or DCGO?

In the previous week, P3 Health Partners and P3 Health Partners both had 1 articles in the media. P3 Health Partners' average media sentiment score of 0.00 equaled DocGo'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment P3 Health Partners 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral DocGo 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

DocGo (DCGO) Competitors

$0.40 0.00 (-0.52%)

As of 09/4/2026 04:00 PM Eastern

Compare

DCGO vs. LFMD, JYNT, PARK, ACH, and PIII

Should you buy DocGo stock or one of its competitors? DocGo's main competitors and comparable companies include LifeMD (LFMD), Joint (JYNT), Park Dental Partners (PARK), Accendra Health (ACH), and P3 Health Partners (PIII). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does DocGo compare to LifeMD?

DocGo (NASDAQ:DCGO) and LifeMD (NASDAQ:LFMD) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their valuation, earnings, dividends, analyst recommendations, risk, profitability, media sentiment and institutional ownership.

DocGo has a beta of 0.94, meaning that its share price is 6% less volatile than the broader market. Comparatively, LifeMD has a beta of 2.04, meaning that its share price is 104% more volatile than the broader market.

In the previous week, DocGo had 1 more articles in the media than LifeMD. MarketBeat recorded 1 mentions for DocGo and 0 mentions for LifeMD. DocGo's average media sentiment score of 0.00 equaled LifeMD'saverage media sentiment score.

Company	Overall Sentiment
DocGo	Neutral
LifeMD	Neutral

56.4% of DocGo shares are owned by institutional investors. Comparatively, 35.5% of LifeMD shares are owned by institutional investors. 5.1% of DocGo shares are owned by company insiders. Comparatively, 17.2% of LifeMD shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

DocGo currently has a consensus target price of $2.38, indicating a potential upside of 489.77%. LifeMD has a consensus target price of $7.57, indicating a potential upside of 145.83%. Given DocGo's higher probable upside, research analysts plainly believe DocGo is more favorable than LifeMD.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DocGo	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33
LifeMD	1 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.70

LifeMD has lower revenue, but higher earnings than DocGo. LifeMD is trading at a lower price-to-earnings ratio than DocGo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DocGo	$322.20M	0.12	-$182.40M	-$1.96	N/A
LifeMD	$194.05M	0.77	$14.35M	-$0.05	N/A

LifeMD has a net margin of 0.10% compared to DocGo's net margin of -65.29%. DocGo's return on equity of -40.42% beat LifeMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DocGo	-65.29%	-40.42%	-24.81%
LifeMD	0.10%	-168.23%	-31.27%

Summary

LifeMD beats DocGo on 8 of the 15 factors compared between the two stocks.

How does DocGo compare to Joint?

DocGo (NASDAQ:DCGO) and Joint (NASDAQ:JYNT) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, media sentiment, valuation, profitability and analyst recommendations.

56.4% of DocGo shares are held by institutional investors. Comparatively, 76.9% of Joint shares are held by institutional investors. 5.1% of DocGo shares are held by company insiders. Comparatively, 30.2% of Joint shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, Joint had 1 more articles in the media than DocGo. MarketBeat recorded 2 mentions for Joint and 1 mentions for DocGo. Joint's average media sentiment score of 0.34 beat DocGo's score of 0.00 indicating that Joint is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DocGo	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Joint	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Joint has lower revenue, but higher earnings than DocGo. DocGo is trading at a lower price-to-earnings ratio than Joint, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DocGo	$322.20M	0.12	-$182.40M	-$1.96	N/A
Joint	$54.90M	2.14	$2.91M	$0.27	30.81

Joint has a net margin of 6.49% compared to DocGo's net margin of -65.29%. Joint's return on equity of 12.02% beat DocGo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DocGo	-65.29%	-40.42%	-24.81%
Joint	6.49%	12.02%	3.47%

DocGo has a beta of 0.94, indicating that its share price is 6% less volatile than the broader market. Comparatively, Joint has a beta of 1.05, indicating that its share price is 5% more volatile than the broader market.

DocGo presently has a consensus target price of $2.38, suggesting a potential upside of 489.77%. Given DocGo's stronger consensus rating and higher probable upside, equities analysts clearly believe DocGo is more favorable than Joint.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DocGo	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33
Joint	0 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Joint beats DocGo on 12 of the 16 factors compared between the two stocks.

How does DocGo compare to Park Dental Partners?

DocGo (NASDAQ:DCGO) and Park Dental Partners (NASDAQ:PARK) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, media sentiment, earnings, institutional ownership, dividends, analyst recommendations, valuation and risk.

56.4% of DocGo shares are owned by institutional investors. 5.1% of DocGo shares are owned by company insiders. Comparatively, 10.6% of Park Dental Partners shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

DocGo presently has a consensus price target of $2.38, indicating a potential upside of 489.77%. Park Dental Partners has a consensus price target of $28.50, indicating a potential upside of 39.50%. Given DocGo's higher possible upside, equities analysts plainly believe DocGo is more favorable than Park Dental Partners.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DocGo	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33
Park Dental Partners	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

Park Dental Partners has lower revenue, but higher earnings than DocGo. DocGo is trading at a lower price-to-earnings ratio than Park Dental Partners, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DocGo	$322.20M	0.12	-$182.40M	-$1.96	N/A
Park Dental Partners	$244.49M	0.40	-$360K	$1.05	19.46

In the previous week, DocGo had 1 more articles in the media than Park Dental Partners. MarketBeat recorded 1 mentions for DocGo and 0 mentions for Park Dental Partners. DocGo's average media sentiment score of 0.00 equaled Park Dental Partners'average media sentiment score.

Company	Overall Sentiment
DocGo	Neutral
Park Dental Partners	Neutral

Park Dental Partners has a net margin of 0.00% compared to DocGo's net margin of -65.29%. Park Dental Partners' return on equity of 0.00% beat DocGo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DocGo	-65.29%	-40.42%	-24.81%
Park Dental Partners	N/A	N/A	N/A

Summary

Park Dental Partners beats DocGo on 10 of the 15 factors compared between the two stocks.

How does DocGo compare to Accendra Health?

DocGo (NASDAQ:DCGO) and Accendra Health (NYSE:ACH) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, analyst recommendations, valuation, media sentiment, profitability, earnings and risk.

In the previous week, DocGo and DocGo both had 1 articles in the media. Accendra Health's average media sentiment score of 1.70 beat DocGo's score of 0.00 indicating that Accendra Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DocGo	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Accendra Health	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

56.4% of DocGo shares are held by institutional investors. 5.1% of DocGo shares are held by company insiders. Comparatively, 2.3% of Accendra Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

DocGo has a beta of 0.94, suggesting that its share price is 6% less volatile than the broader market. Comparatively, Accendra Health has a beta of 1.53, suggesting that its share price is 53% more volatile than the broader market.

Accendra Health has a net margin of -11.41% compared to DocGo's net margin of -65.29%. Accendra Health's return on equity of -4.02% beat DocGo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DocGo	-65.29%	-40.42%	-24.81%
Accendra Health	-11.41%	-4.02%	0.70%

DocGo has higher earnings, but lower revenue than Accendra Health. Accendra Health is trading at a lower price-to-earnings ratio than DocGo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DocGo	$322.20M	0.12	-$182.40M	-$1.96	N/A
Accendra Health	$2.73B	0.03	-$1.10B	-$3.91	N/A

DocGo presently has a consensus target price of $2.38, suggesting a potential upside of 489.77%. Accendra Health has a consensus target price of $1.50, suggesting a potential upside of 23.46%. Given DocGo's stronger consensus rating and higher possible upside, equities research analysts plainly believe DocGo is more favorable than Accendra Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DocGo	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33
Accendra Health	1 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.80

Summary

DocGo beats Accendra Health on 9 of the 15 factors compared between the two stocks.

How does DocGo compare to P3 Health Partners?

P3 Health Partners (NASDAQ:PIII) and DocGo (NASDAQ:DCGO) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, earnings, institutional ownership, profitability, valuation, analyst recommendations, risk and dividends.

P3 Health Partners has a net margin of -6.55% compared to DocGo's net margin of -65.29%. P3 Health Partners' return on equity of 0.00% beat DocGo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
P3 Health Partners	-6.55%	N/A	-16.40%
DocGo	-65.29%	-40.42%	-24.81%

P3 Health Partners presently has a consensus target price of $17.00, suggesting a potential upside of 81.82%. DocGo has a consensus target price of $2.38, suggesting a potential upside of 489.77%. Given DocGo's stronger consensus rating and higher possible upside, analysts clearly believe DocGo is more favorable than P3 Health Partners.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
P3 Health Partners	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
DocGo	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33

7.8% of P3 Health Partners shares are held by institutional investors. Comparatively, 56.4% of DocGo shares are held by institutional investors. 10.9% of P3 Health Partners shares are held by company insiders. Comparatively, 5.1% of DocGo shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, P3 Health Partners and P3 Health Partners both had 1 articles in the media. P3 Health Partners' average media sentiment score of 0.00 equaled DocGo'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
P3 Health Partners	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
DocGo	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

P3 Health Partners has higher revenue and earnings than DocGo. P3 Health Partners is trading at a lower price-to-earnings ratio than DocGo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
P3 Health Partners	$1.46B	0.05	-$147.95M	-$33.00	N/A
DocGo	$322.20M	0.12	-$182.40M	-$1.96	N/A

P3 Health Partners has a beta of 1.63, indicating that its stock price is 63% more volatile than the broader market. Comparatively, DocGo has a beta of 0.94, indicating that its stock price is 6% less volatile than the broader market.

Summary

P3 Health Partners and DocGo tied by winning 7 of the 14 factors compared between the two stocks.

Get DocGo News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DCGO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

DCGO vs. The Competition

Export

Metric	DocGo	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$40.05M	$10.10B	$7.27B	$12.91B
Dividend Yield	N/A	2.59%	2.53%	8.90%
P/E Ratio	-0.21	34.60	272.43	25.42
Price / Sales	0.12	4.86	594.02	75.77
Price / Cash	7.32	121.75	77.39	52.28
Price / Book	0.42	3.99	12.85	6.17
Net Income	-$182.40M	$313.25M	$3.48B	$349.50M
7 Day Performance	1.31%	1.06%	0.99%	-0.15%
1 Month Performance	-35.86%	0.33%	5.49%	1.02%
1 Year Performance	-74.51%	15.31%	24.34%	14.50%

DocGo Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
DCGO DocGo	2.8925 of 5 stars	$0.40 -0.5%	$2.38 +489.8%	-73.3%	$40.05M	$322.20M	N/A	3,568
LFMD LifeMD	2.9877 of 5 stars	$3.14 -3.7%	$7.57 +141.1%	-51.0%	$151.35M	$194.05M	N/A	230
JYNT Joint	2.3143 of 5 stars	$8.43 +0.2%	N/A	-22.0%	$119.20M	$54.90M	31.22	320	News Coverage Analyst Upgrade
PARK Park Dental Partners	3.4245 of 5 stars	$20.85 -4.3%	$28.50 +36.7%	N/A	$99.25M	$244.49M	19.86	1,212	Positive News Analyst Upgrade Gap Down
ACH Accendra Health	2.215 of 5 stars	$1.23 +1.2%	$1.50 +22.4%	N/A	$94.20M	$2.73B	N/A	6,500	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:DCGO) was last updated on 9/5/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

DocGo (DCGO) Competitors

DCGO vs. LFMD, JYNT, PARK, ACH, and PIII

How does DocGo compare to LifeMD?

Summary

How does DocGo compare to Joint?

Summary

How does DocGo compare to Park Dental Partners?

Summary

How does DocGo compare to Accendra Health?

Summary

How does DocGo compare to P3 Health Partners?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DCGO vs. The Competition

DocGo Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

DocGo (DCGO) Competitors

DCGO vs. LFMD, JYNT, PARK, ACH, and PIII

How does DocGo compare to LifeMD?

Which has more volatility & risk, DCGO or LFMD?

Does the media favor DCGO or LFMD?

Do insiders and institutionals hold more shares of DCGO or LFMD?

Do analysts prefer DCGO or LFMD?

Which has better valuation and earnings, DCGO or LFMD?

Is DCGO or LFMD more profitable?

Summary

How does DocGo compare to Joint?

Do insiders & institutionals hold more shares of DCGO or JYNT?

Does the media prefer DCGO or JYNT?

Which has preferable earnings and valuation, DCGO or JYNT?

Is DCGO or JYNT more profitable?

Which has more risk & volatility, DCGO or JYNT?

Do analysts prefer DCGO or JYNT?

Summary

How does DocGo compare to Park Dental Partners?

Do institutionals & insiders have more ownership in DCGO or PARK?

Do analysts recommend DCGO or PARK?

Which has stronger earnings and valuation, DCGO or PARK?

Does the media refer more to DCGO or PARK?

Is DCGO or PARK more profitable?

Summary

How does DocGo compare to Accendra Health?

Does the media prefer DCGO or ACH?

Do insiders and institutionals believe in DCGO or ACH?

Which has more volatility and risk, DCGO or ACH?

Is DCGO or ACH more profitable?

Which has higher earnings and valuation, DCGO or ACH?

Do analysts recommend DCGO or ACH?

Summary

How does DocGo compare to P3 Health Partners?

Is PIII or DCGO more profitable?

Do analysts rate PIII or DCGO?

Do insiders & institutionals hold more shares of PIII or DCGO?

Does the media favor PIII or DCGO?

Which has stronger earnings & valuation, PIII or DCGO?

Which has more risk and volatility, PIII or DCGO?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DCGO vs. The Competition

DocGo Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools